{
    "Trade/Device Name(s)": [
        "Randox RX daytona plus magnesium (Mg)"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K162200",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991576"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGJ"
    ],
    "Summary Letter Date": "March 22, 2017",
    "Summary Letter Received Date": "March 24, 2017",
    "Submission Date": "April 28, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1495"
    ],
    "Regulation Name(s)": [
        "Magnesium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Magnesium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine",
        "Lithium heparinized plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX daytona plus"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Randox RX daytona plus magnesium (Mg) colorimetric reagent for quantitative magnesium determination on RX daytona plus analyzer",
    "Indications for Use Summary": "Intended for the quantitative in vitro determination of magnesium concentration in serum, urine and lithium heparinized plasma to aid in diagnosis and treatment of hypomagnesemia and hypermagnesemia.",
    "fda_folder": "Clinical Chemistry"
}